Molecular classification and construction of the risk signature for diffuse large B-cell lymphoma based on vitamin B6 metabolism
Abstract Background and objectives Diffuse large B-cell lymphoma (DLBCL), characterized by high heterogeneity, shows significant differences in treatment responses and prognosis among patients. The underlying mechanisms of vitamin B6 metabolism in DLBCL remain unclear. This study aims to explore vit...
Saved in:
| Main Authors: | Wen Wei, Dao Xin, Huawei Weng, Le Yu, Lingxi Jiang, Yuxin Man |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-07-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-03122-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Construction and validation of a risk scoring model for diffuse large B-cell lymphoma based on endoplasmic reticulum stress-related and immune-related genes
by: Mengyuan Chang, et al.
Published: (2025-07-01) -
Serum hepatitis B core antibody as the prognostic factor for diffuse large B-cell lymphoma
by: Yi Rong, et al.
Published: (2025-05-01) -
Therapeutic landscape of primary refractory and relapsed diffuse large B-cell lymphoma: Recent advances and emerging therapies
by: Allison M. Bock, et al.
Published: (2025-07-01) -
Clinical and Hematological Predictors of Response to First-Line Therapy in Patients with Diffuse Large B-Cell Lymphoma
by: SV Samarina, et al.
Published: (2018-12-01) -
Clinical characteristics and treatment evaluation of diffuse large B-cell lymphoma in Chinese children and adolescents: a multicenter clinical study of China-Net childhood lymphoma group B-NHL-2017
by: Yang Fu, et al.
Published: (2025-07-01)